Alternatively, by going upstream and targeting PLCβ1 with CTP‐miRNA106a, and suppressing both IP3 and PKC activity, multiple signalling sources of HF are influenced and suppressed. The gene discussed is PRRT2; the disease is hydrops fetalis.